In metaplastic breast cancer, CRYAB was found to be highly expressed and associated with brain metastasis, and silencing the CRYAB gene using RNA interference technology significantly reduced tumor invasion and metastasis ability [7,8]. This evidence concerns the gene CRYAB and neoplasm.